Literature DB >> 35363051

Why Patients Fall Through the Cracks: Assessment of Patients' Overactive Bladder Treatment.

Emily R W Davidson1, Lia Miceli1, Katie Propst1.   

Abstract

Objective: Despite an established treatment algorithm for overactive bladder (OAB), it is unclear how many patients proceed through each step. Our objective was to evaluate the percentage of patients receiving each step of care and identify reasons why patients did not receive certain treatments.
Methods: This was a retrospective cohort study with cross-sectional survey of new OAB patients. The medical record was queried for relevant patient characteristics and documentation of conservative, medical, and third-line therapies. In the survey, patients were asked about current bladder symptoms and reasons why they did not use certain treatments. Descriptive statistics were used for analysis.
Results: One hundred eleven patients met the inclusion criteria; the most common diagnosis was mixed incontinence (40%, n = 45). The median number of visits for OAB was 2 (range 1-8). On retrospective analysis, 64% (71) of patients had documented attempts at conservative therapy. Seventy-six percent (84) of patients attempted medical therapy, and only 11% (12) progressed to any third-line therapy. Fifty-nine percent (64) of eligible patients responded to the survey. Fifty-three percent (34) of respondents reported persistent moderate to very severe bother due to bladder symptoms. Thirty percent to fifty percent of patients who did not attempt one or more of the three levels of OAB therapy reported that they were never offered that treatment option. Conclusions: Many patients do not progress to the next steps in OAB therapy despite failure of more conservative treatments. Barriers to care included limited follow-up and education about other therapy options. A formalized institutional care pathway may lead to improved OAB treatment.

Entities:  

Keywords:  delivery of health care; lower urinary tract symptoms; nocturia; overactive; urge; urinary bladder; urinary incontinence

Mesh:

Year:  2022        PMID: 35363051      PMCID: PMC9527055          DOI: 10.1089/jwh.2021.0635

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   3.017


  24 in total

1.  Severe depression and anxiety in women with overactive bladder.

Authors:  Iane Glauce Ribeiro Melotti; Cássia Raquel Teatin Juliato; Mariana Tanaka; Cassio Luiz Zanettini Riccetto
Journal:  Neurourol Urodyn       Date:  2017-04-13       Impact factor: 2.696

2.  An overactive bladder online self-management program with embedded avatars: a randomized controlled trial of efficacy.

Authors:  Allen D Andrade; Ramanakumar Anam; Chandana Karanam; Pamela Downey; Jorge G Ruiz
Journal:  Urology       Date:  2015-01-10       Impact factor: 2.649

3.  Care Pathway Effect on In-Hospital Care for ST-Elevation Myocardial Infarction.

Authors:  Daan Aeyels; Luk Bruyneel; Peter R Sinnaeve; Marc J Claeys; Sofie Gevaert; Danny Schoors; Massimiliano Panella; Walter Sermeus; Kris Vanhaecht
Journal:  Cardiology       Date:  2018-08-10       Impact factor: 1.869

4.  Persistence and adherence with urinary antispasmodic medications among employees and the impact of adherence on costs and absenteeism.

Authors:  Nathan L Kleinman; Kevin Odell; Chieh-I Chen; Amy Atkinson; Kelly H Zou
Journal:  J Manag Care Spec Pharm       Date:  2014-10

Review 5.  Affective symptoms and the overactive bladder - a systematic review.

Authors:  Desiree Vrijens; Jamie Drossaerts; Gommert van Koeveringe; Philip Van Kerrebroeck; Jim van Os; Carsten Leue
Journal:  J Psychosom Res       Date:  2014-11-27       Impact factor: 3.006

6.  A retrospective longitudinal evaluation of new overactive bladder patients in an FPMRS urologist practice: Are patients following up and utilizing third-line therapies?

Authors:  Chris Du; William T Berg; Alexandra R Siegal; Zhenyue Huang; Anh Nguyen; Alice Cheung; Sina Mehraban-Far; Rebecca Anderson; Sophia Jacob; Jason Kim
Journal:  Neurourol Urodyn       Date:  2020-11-16       Impact factor: 2.696

7.  Improved blood pressure control associated with a large-scale hypertension program.

Authors:  Marc G Jaffe; Grace A Lee; Joseph D Young; Stephen Sidney; Alan S Go
Journal:  JAMA       Date:  2013-08-21       Impact factor: 56.272

8.  Small-Group, Community-Member Intervention for Urinary and Bowel Incontinence: A Randomized Controlled Trial.

Authors:  Heidi W Brown; Emilie J Braun; Meg E Wise; Shannon Myers; Zhanhai Li; Emmanuel Sampene; Sierra M Jansen; D Paul Moberg; Jane E Mahoney; Rebecca G Rogers
Journal:  Obstet Gynecol       Date:  2019-09       Impact factor: 7.623

9.  Social media analytics of overactive bladder posts: what do patients know and want to know?

Authors:  Gabriela Gonzalez; Kristina Vaculik; Carine Khalil; Yuliya Zektser; Corey W Arnold; Christopher V Almario; Brennan M R Spiegel; Jennifer T Anger
Journal:  Int Urogynecol J       Date:  2021-03-12       Impact factor: 1.932

Review 10.  Evaluation and management of overactive bladder: strategies for optimizing care.

Authors:  Marcella G Willis-Gray; Alexis A Dieter; Elizabeth J Geller
Journal:  Res Rep Urol       Date:  2016-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.